News | Radiology Imaging | December 28, 2015 | Dave Fornell

Toshiba May Sell its Healthcare Division as Part of its Financial Reforms

Scandal following its announcement of intentionally posting false financial reports results in job cuts and putting its healthcare division up for sale

Toshiba May Sell its Healthcare Division as Part of its Financial Reforms

December 28, 2015 — Toshiba announced Dec. 21 it is considering selling off its healthcare division as part of its restructuring plans in the aftermath of its falsified financial reporting scandal from earlier this year. 

In February 2015, Toshiba revealed it had manipulated its financial figures for the past seven years to improve the image of its bottom line following the global economic downturn starting in 2008. In September Toshiba submitted amended financial reports from 2015 back to April 2009 to correct the misinformation on the previous reports. 

The Japanese Securities and Exchange Surveillance Commission imposed a penalty of 7.3 billion Yen (more than $60 million in U.S. dollars) due to the false financial statements. Toshiba also created an independent auditing group to investigate the financials, leading to the resignation of five members of the company’s Board of Directors.

The revelation of the false reporting statements has shown Toshiba to be in the red with some of its businesses. Its recent financial reports showed stagnation in its home appliance business, part of its lifestyles product and services divisions that include TVs and personal computers.  The division posted big revenue declines in 2015. 

During the Dec. 21 press conference, the company explained how it would revitalize itself in 2016. Beyond implementing financial reforms in its reporting, this includes cutting 10,600 jobs, mostly from its lifestyles and semiconductor divisions and from its corporate staff.  The company also prioritized selling shares of its healthcare segment to outside investors. The company said while the business has been profitable, it needs additional research and development, and management resources to continue its expansion.  The company said much of the R&D in this segment has been in creating next generation computed tomography (CT) systems

It is refocusing efforts in the energy and information storage divisions and is inviting outside majority shareholders in the healthcare business to secure management resources necessary for further growth. 

In its December financial report, Toshiba said its healthcare segment net sales grew to a total of $3.4 billion. The division's products include imaging systems for CT, MRI, PET-CT, angiography, digital X-ray, ultrasound and advanced visualization software.

Related Content

William T. Thorwarth, M.D., FACR, chief executive officer of the ACR

William T. Thorwarth, M.D., FACR, chief executive officer of the ACR

News | Population Health | December 13, 2019
December 13, 2019 — The ...
Sponsored Content | Videos | Digital Radiography (DR) | December 12, 2019
Vieworks to present NEW DR detectors, VIVIX-S V series.
CT_Pediatric_Scan_Philips_Vereos_CT_RSNA 2016

Image courtesy of Philips Healthcare

News | Pediatric Imaging | December 10, 2019
December 10, 2019 — More than half of people who received...
RaySearch Laboratories AB (publ) has experienced strong growth in recent years, creating the need for larger and more efficient premises
News | Radiation Therapy | December 09, 2019
December 9, 2019 — Karin Gedda, architect and i
Legislation ends surprise medical bills; funds Community Health Centers for five years; increases the purchasing age of tobacco to 21; lowers prescription drug and other medical costs by requiring more transparency and competition
News | Population Health | December 09, 2019
December 9, 2019 — Senate Health Committee Chairman...
MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier